"Not Even Enough For...": Vaccine Panel Chief On Pfizer, Moderna Offers | Read

All US-based vaccine makers are insisting on indemnity and liability clauses and India's reluctance to meet them is slowing down their entry in the market, NK Arora, head of the government's vaccine panel told NDTV yesterday. He, however, revealed that the country's plan to vaccinate all eligible adults by December does not depend on foreign vaccines. Dr Arora, however, indicated that the government would have reconsidered its stance on indemnity if the vaccine makers were willing to provide a larger amount of vaccines -- like 100 or 200 million doses.